Impetus Grants support scientists pursuing unconventional longevity research and disease-tracking datasets to open new areas of aging science, inform AI reasoning, and seed paths toward treatments.
Funder: Norn Group
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: Up to $500,000 per grant; planned AI-enabling datasets round targets $15 million for 50 grants
Summary: Impetus Grants support unconventional longevity research that could transform the field but would otherwise go unfunded.
Key Information: Recipient institution overhead is capped at 10%.
Impetus Grants is Norn Group’s rapid grantmaking program for scientists pursuing ideas that could change the trajectory of aging research. It prioritizes high-risk, high-reward work over incremental additions to existing knowledge, focusing on ideas too speculative for government funding and too early for company formation. The program aims to seed new research areas and paths toward treatments, while attracting exceptional scientists who might otherwise work outside aging research.
The planned AI-enabling datasets round focuses on experiments that track disease over time, linking molecular and cellular changes to organ function and health. These datasets are intended to help AI reason about disease trajectories, causality, and treatments. Because longitudinal biological data take years to build, the program emphasizes starting their development now. Previous projects span aging biomarkers, cellular atlases, DNA repair, senescent-cell targeting, and human intervention studies.